We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.
- Authors
Chen, Tzu-Yi; Mihalopoulos, Meredith; Zuluaga, Laura; Rich, Jordan; Ganta, Teja; Mehrazin, Reza; Tsao, Che-Kai; Tewari, Ash; Gonzalez-Kozlova, Edgar; Badani, Ketan; Dogra, Navneet; Kyprianou, Natasha
- Abstract
Extracellular vesicles (EVs)—including apoptotic bodies, microvesicles, and exosomes—are released by almost all cell types and contain molecular footprints from their cell of origin, including lipids, proteins, metabolites, RNA, and DNA. They have been successfully isolated from blood, urine, semen, and other body fluids. In this review, we discuss the current understanding of the predictive value of EVs in prostate and renal cancer. We also describe the findings supporting the use of EVs from liquid biopsies in stratifying high-risk prostate/kidney cancer and advanced disease, such as castration-resistant (CRPC) and neuroendocrine prostate cancer (NEPC) as well as metastatic renal cell carcinoma (RCC). Assays based on EVs isolated from urine and blood have the potential to serve as highly sensitive diagnostic studies as well as predictive measures of tumor recurrence in patients with prostate and renal cancers. Overall, we discuss the biogenesis, isolation, liquid-biopsy, and therapeutic applications of EVs in CRPC, NEPC, and RCC.
- Subjects
RENAL cancer; EXTRACELLULAR vesicles; PROSTATE cancer; RENAL cell carcinoma; PROSTATE cancer patients; VESICLES (Cytology); BODY fluids; ANDROGEN receptors; CIRCULATING tumor DNA
- Publication
International Journal of Molecular Sciences, 2023, Vol 24, Issue 19, p14713
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms241914713